Concordia International Corp. (TSE:CXR – Get Free Report) (NASDAQ:CXRX) shares dropped 1.5% during trading on Monday . The stock traded as low as C$25.01 and last traded at C$25.04. Approximately 73,541 shares were traded during trading, an increase of 1,714% from the average daily volume of 4,054 shares. The stock had previously closed at C$25.43.
Concordia International Price Performance
The stock has a market cap of C$1.22 billion and a P/E ratio of 0.07. The business’s 50 day moving average is C$25.04. The company has a current ratio of 2.10, a quick ratio of 1.66 and a debt-to-equity ratio of 457.02.
About Concordia International
Concordia International Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies.
Featured Articles
- Five stocks we like better than Concordia International
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Value Stocks You Can Buy Before They Become Big
- Investing in Travel Stocks Benefits
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Concordia International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia International and related companies with MarketBeat.com's FREE daily email newsletter.
